Imai H, Kaira K, Masubuchi K, Minato K. Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study. Curr Oncol. 2022. 29. 1. 163-172
Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, et al. A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab. Sci Rep. 2022. 12. 1. 22557
Yamaguchi O, Atarashi K, Yoshimura K, Shiono A, Mouri A, Nishihara F, Miura Y, Hashimoto K, Miyamoto Y, Uga H, et al. Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1. BMC Cancer. 2022. 22. 1. 1325
Kagamu H, Yamasaki S, Kitano S, Yamaguchi O, Mouri A, Shiono A, Nishihara F, Miura Y, Hashimoto K, Imai H, et al. Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy. Cancer Res. 2022. 82. 24
Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, et al. Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival. Thorac Cancer. 2022. 13. 19. 2776-2785
Neuroendocrine tumor of the breast with pulmonary metastasis 30 years after mastectomy
(32nd Congress of the European Society of Pathology and XXXIII International Congress of the International Academy of Pathology (Virchows Archiv) 2020)
